Dr. Manuel Ramon Sacapano, MD

Dr. Sacapano practices at Los Angeles Community Hospital in Los Angeles, California, part of Prospect Health.

Dr. Sacapano's NPI, 1851315980, was assigned on July 26, 2006. Dr. Sacapano graduated from Loma Linda University School Of Medicine in 2000. Dr. Sacapano holds California license A77588.

Dr. Sacapano's primary practice is Los Angeles Community Hospital, at 4081 E Olympic Blvd, Los Angeles, CA 90023 in Los Angeles County. The practice phone is (323) 267-0477.

Dr. Sacapano's primary practice is Los Angeles Community Hospital in Los Angeles, California, part of Prospect Health. Dr. Sacapano is also affiliated with L.A. Downtown Medical Center. The medical group on file is Global Integrated Medical Group. Dmand AI also links Dr. Sacapano to 1 more hospital, 6 skilled nursing facilities, 5 home health agencies, 2 medical groups, 1 group practice or clinic and 1 hospice, each named with a free account. Dr. Sacapano's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sacapano practices, 16 sites in all. Vendor and product names are available with a free account.

General practice is Dr. Sacapano's primary specialty in the NPI Registry, under taxonomy code 208D00000X. Dr. Sacapano is licensed in California.

CMS data shows 14,716 Medicare services from Dr. Sacapano across 20 procedure codes in 2024, for 1,706 Medicare patients. Medicare paid $1,252,549 for them.

CMS counts 1,706 Medicare patients who saw Dr. Sacapano in 2024. The largest group is 65 to 74, with 698 patients. 75% of them have arthritis, and 75% have high blood pressure. 93% are also on Medicaid. Their average risk score is 2.19, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sacapano's median patient age at 71, with 52% women.

In 2024, Dr. Sacapano wrote 13,345 Medicare Part D claims for 491 patients. 85% of them were for generic drugs. CMS names the drug for 12,526 of them, across 189 drugs with 11 or more claims each, at $778,406 in total drug cost. In 2023, CMS named 10,813 claims across 179 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Sacapano for performance year 2024, reported individually. Dr. Sacapano accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Sacapano, published from 2007 to 2008. 2008 was the busiest year, with 2. The most frequent topics are Brain Neoplasms, Blood-Brain Barrier and Capillary Permeability. Dr. Sacapano has published most often in Brain Res. Dr. Sacapano's most frequent co-author is Keith Lanier Black, MD.

CMS Open Payments shows 11 general payments to Dr. Sacapano from 8 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $103.

Dr. Sacapano graduated from Loma Linda University School Of Medicine in 2000. Dr. Sacapano is a member of ACEP and SHM.

Dr. Sacapano is in network with 2 carriers, including CMS Medicare and Molina. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.